TOP2A and breast carcinoma: Moreover, we found six sex-biased genes (EGFR, CDK6, PRKCB, PDCD1, KCNH2, FCGR3B, and TOP2A) in BRCA were the therapeutic targets of breast cancer (Supplementary Fig. S9).